ASPIRIN, SALICYLATE, SULFITE AND TARTRAZINE INDUCED BRONCHOCONSTRICTION - SAFE DOSES AND CASE-DEFINITION IN EPIDEMIOLOGIC STUDIES

Citation
Eh. Corder et Ce. Buckley, ASPIRIN, SALICYLATE, SULFITE AND TARTRAZINE INDUCED BRONCHOCONSTRICTION - SAFE DOSES AND CASE-DEFINITION IN EPIDEMIOLOGIC STUDIES, Journal of clinical epidemiology, 48(10), 1995, pp. 1269-1275
Citations number
22
Categorie Soggetti
Public, Environmental & Occupation Heath","Medicine, General & Internal
ISSN journal
08954356
Volume
48
Issue
10
Year of publication
1995
Pages
1269 - 1275
Database
ISI
SICI code
0895-4356(1995)48:10<1269:ASSATI>2.0.ZU;2-9
Abstract
Allergic-like reactions to chemical components of foods and medicines may be common. The prevalence of idiosyncratic reactions to aspirin, s alicylate, metabisulfite and tartrazine is not known. We used a tertia ry referral clinic population to estimate safe exposure doses for epid emiological studies. A 15% decrease in the amount of air expired in on e second was defined a positive response. The median effective molar d oses of the agents were remarkably similar: metabisulfite 0.19 mM, 34. 4 mg [95% confidence interval (CI) 0.14, 0.27 mM]; tartrazine 0.10 M, 55.0 mg (95% CI 0.05, 0.21 mM); aspirin 0.09 mM, 16.5 mg (95% CI 0.04, 0.19 mM); and salicylate 0.11 mM, 15.3 mg (95% CI 0.05, 0.27 mM). Dos es to which the most sensitive (5%) and practically all (95%) suscepti ble persons might respectively respond are: metabisulfite 4.6 mg, 255. 8 mg; tartrazine 3.4 mg, 885.6 mg; aspirin 0.8 mg, 332.3 mg; and salic ylate 2.6 mg, 89.9 mg. Doses within these ranges can be used in epidem iological studies.